The Feel Good Lab

Operating

Feel Good Lab LLC

Software & AI · Founded 2016

The Feel Good Lab is giving the OTC pain relief category a much-needed makeover. 1 out of 3 U.S. adults suffers from chronic pain without any healthy options to treat it, until now.

Post-money valuation ⓘ

$9.7M

As of May 2021 · from Reg CF Offering (2020) · pre-money + amount raised, not a traded price

Total raised

$803,116

Crowd $628K · Private $175K · 3 rounds since 2018

Latest share price

$1.05

Reg CF · Common Stock · Nov 2020 offering price

Financials

FY2018–FY2021 · from SEC filings · hover any figure for its source

$185K

−$181K

2018

$243K

−$333K

2019

$113K

−$492K

2020

$131K

−$424K

2021

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2018 reviewed

FY2019 reviewed

FY2020

FY2021

Income statement

Revenue

$185,157

$242,935

$112,546

$131,340

Cost of goods sold

$101,651

$123,251

$124,950

$107,528

Gross margin

45%

49%

-11%

18%

Net income

-$181,296

-$333,334

-$491,804

-$423,847

Taxes paid

Balance sheet

Cash

$158,217

$122,711

$148,661

$148,983

Accounts receivable

$20,047

$33,804

Total assets

$269,217

$259,290

$143,903

$234,483

Short-term debt

$112,969

$70,000

Long-term debt

$325,000

$512,031

$922,512

Total liabilities

$325,000

$625,000

$992,512

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in

$9.1M

pre-money

Reg CF · Common · Nov 2020

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Nov 2020Closedvia Netcapital

Raised $628.1K / $1.1MPost-money $9.7M

Rule 506(c) · Equity · Nov 2020Closed

Raised —

Rule 506(b) · Aug 2018Closed

Raised $175KInvestors 4

Team

3 people

CJ Forse

Board Member

Kyle Fitzpatrick

Board Member

Ryan Gresh

Principal Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 6 annual reports (FY2020–FY2025)

4 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 16 filings on EDGAR

Form C-TRNov 30, 20230001669191-23-001140
EDGAR
Form C-ARApr 28, 20220001669191-22-000443
EDGAR
Form C-UAug 6, 20210001669191-21-000778
EDGAR
Form C/AApr 29, 20210001669191-21-000478
EDGAR
Form C/AMar 29, 20210001669191-21-000324
EDGAR
Form C/AMar 5, 20210001669191-21-000216
EDGAR
Form C/AMar 1, 20210001669191-21-000190
EDGAR
Form C/AFeb 23, 20210001669191-21-000173
EDGAR

Source: ManualCIK 0001750939Share price $1.05

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.